SCHEMBL19871663

SCHEMBL19871663

CCc1c(OC)cc(Cl)cc1C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 3/20 0.38
▸ HTR2C P28335 1/20 0.38
▸ GAA P10253 2/20 0.33
▸ AR P10275 1/20 0.33
▸ NR3C1 P04150 1/20 0.33
▸ NR3C2 P08235 1/20 0.33
▸ ERN1 O75460 1/20 0.33
▸ DDR1 Q08345 2/20 0.33
▸ MAPT P10636 3/20 0.33
▸ HTT P42858 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MRGPRX4 Q96LA9 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ PTGS2 P35354 1/20 0.32
▸ ATM Q13315 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ CNR2 P34972 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22017132 0.81 HTR2A (0.39) HTR2AHTR2CNR3C1NR3C2PTGS2
SCHEMBL25745801 0.81 ACHE (0.41) HTR2AHTR2CARNR3C1NR3C2
SCHEMBL16009749 0.81 HTR2A (0.39) HTR2AHTR2CARALDH1A1MEN1
SCHEMBL25745865 0.78 HTR2A (0.37) HTR2AHTR2CPTGS2LMNA
SCHEMBL21586427 0.77 ALDH1A1 (0.39) HTR2AHTR2CGAAARNR3C1
SCHEMBL18007684 0.75 HTR2A (0.40) HTR2AHTR2CGAAARERN1
SCHEMBL19871672 0.72 HTR2A (0.38) HTR2AHTR2CGAAARERN1
SCHEMBL21264177 0.71 ATM (0.43) HTR2AHTR2CARMAPTHTT
SCHEMBL4156609 0.70 HTR2A (0.36) HTR2AHTR2CARATM
SCHEMBL24007023 0.68 HTR2A (0.41) HTR2AHTR2CGAAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180044287-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME INFLAZOME LIMITED (IE) 2018-02-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044287-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME NLRP3, PYCARD, IAPP HTR2A 4114/4885HTR2C 4379/4885GAA 706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback